Barlow Scientific, Inc.

Olympia, WA 98502

SBIR Award Summary

Total Number of Awards 49
Total Value of Awards $4.81MM
First Award Date 05/01/87
Most Recent Award Date 03/06/12

Key Personnel

Last Name Name Awards Contact
Barlow Clyde H Barlow 28
Kelly Jeffrey J Kelly 20
Farrell David H Farrell 1

49 Awards Won

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-11-096
Budget: 03/06/12 - 02/28/13

DESCRIPTION (provided by applicant): This proposal outlines the development of a new product, and a new methodological approach to the simultaneous measurement of subdermal PO2 and hemoglobin oxygen saturation in skin. The product, "Oxyspheres", will find wide use in the development of healing therapies for skin grafts, skin ulcers, and amputati...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-08-050
Budget: 02/01/10 - 06/30/11

DESCRIPTION (provided by applicant): Fluorescent tagging of cells using dyes, fluorescent proteins, and quantum dots forms the basis for many powerful analytical methods in modern biology. Locating these cells within entire animals is necessary to study cell delivery, differentiation and gene expression. The Phase II SBIR research is developing ...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-08-050
Budget: 03/09/09 - 01/31/10

DESCRIPTION (provided by applicant): Fluorescent tagging of cells using dyes, fluorescent proteins, and quantum dots forms the basis for many powerful analytical methods in modern biology. Locating these cells within entire animals is necessary to study cell delivery, differentiation and gene expression. The Phase II SBIR research is developing ...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-07-80
Budget: 03/01/08 - 08/31/08

DESCRIPTION (provided by applicant): Regional blood flow distributions in organs of experimental animals can be measured effectively by combining fluorescent microsphere methods with imaging cryomicrotomy. The number of flow measurements that can be made in a single animal is currently limited because using different colors of fluorescent micros...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-06-06
Budget: 08/01/06 - 01/31/07

DESCRIPTION (provided by applicant): Locating fluorescently-tagged cells in whole organisms is important to the development of gene therapy, stem cell therapy delivery methods, and for drug research. This project will develop an intelligent microtome to identify fluorescently labeled cells in whole mice and to collect those cells in thin section...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 09/01/05 - 08/31/06

DESCRIPTION (provided by applicant): This research involves the development of a method to quantify regional flow in tissues using automated instrumental procedures. Phase I results have demonstrated that fluorescent antibodies, specific to antigens in capillary endothelium, can be spatially located in sequential fluorescence images recorded ...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 01/01/05 - 06/30/05

DESCRIPTION (provided by applicant): In order to assure the physiological status of small experimental animals, pulmonary and circulatory functions must be monitored accurately and frequently. Arterial blood-gas measurements are critical for this monitoring, however, repeated measurements can affect blood volume and hematocrit, especially in sma...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 09/15/04 - 08/31/05

DESCRIPTION (provided by applicant): This research involves the development of a method to quantify regional flow in tissues using automated instrumental procedures. Phase I results have demonstrated that fluorescent antibodies, specific to antigens in capillary endothelium, can be spatially located in sequential fluorescence images recorded ...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 02/29/04 - 02/28/05

DESCRIPTION (provided by applicant): In order for a tumor to grow, it must obtain nutrients and oxygen from its host and continuously evolve new vasculature to deliver supplies to its multiplying cells. Exciting current research studies of interventions that reduce or reverse malignant growth of tumors using angiogenesis inhibitors and vasoacti...

Phase 1 STTR

Agency: Department of Health & Human Services
Topic:
Budget: 08/20/03 - 07/31/04

We have identified a novel heparin-like peptidyl coagulation inhibitor that is a peptide fragment of a naturally-occurring human fibrinogen isoform, gammaA/gamma' fibrinogen. The peptide is active as an anticoagulant in whole plasma, and is unlikely to elicit an immune response, since it is a normal fibrinolytic cleavage product of this fibrino...

Load More